To the question of creating conditions for determining the sterility of drugs in the microbiological laboratory

DOI: https://doi.org/10.29296/25419218-2020-04-01
Issue: 
4
Year: 
2020

O.V. Gunar, А.V. Dorenskaya, V.Sh. Votiakova Scientific Centre for Expert Evaluation of Medicinal Products, 8/2 Petrovsky Blvd, Moscow, 127051, Russian Federation

Correspondence of the quality of drugs in terms of «Sterility» guarantees the safety of the use of drugs for injection and infusion, eye drops and films, pharmaceutical substances and excipients, including biological drugs and their solvents, which must be sterile in accordance with regulatory documents and pharmacopeia articles. In the article, the authors consider the necessary conditions for the organization and conduct of the sterility test of drugs. The creation, operation and maintenance of the described conditions is in the area of responsibility of production, control and expert microbiological laboratories. Among the necessary conditions, the following are highlighted: a special aseptic room with a certain confirmed purity class; microbiological monitoring; proven sterility of all consumables, solutions and culture media used; test methods used with proven applicability. Actively discusses the issue that arises when a contaminated sample is detected. The revealed fact requires an investigation of the causes of the situation and a possible further recognition of the drug as poor in terms of «Sterility». The materials are included in the draft General Pharmacopoeia Monograph «Conditions for determining the sterility of drugs», which is currently under consideration and approval in the prescribed manner for further inclusion in the State Pharmacopoeia of the Russian Federation.

Keywords: 
quality of medicines
sterility

References: 
  1. Gosudarstvennaja farmakopeja Rossijskoj Federatsii XIV izd. [Elektronnoe izdanie] Rezhim dostupa: https:// femb.ru/femb/pharmacopea.php [The State Pharmacopoeia of The Russian Federation, XIV-ed. [Electronic resource]. Access mode: https:// femb.ru/femb/pharmacopea.php (in Russian)].
  2. Prikaz Ministerstva promyshlennosti i torgovli ot 14 ijunja 2013 g. №916 «Ob utverzhdenii Pravil organizatsii proizvodstva i kontrolja kachestva lekarstvennyh sredstv». [Order of the Ministry of Industry and Trade of June 14, 2013 №916 «On approval of the Rules for the organization of production and quality control of medicines» (in Russian)].
  3. Sandle T. Designing and Implementing an Environmental Monitoring Program. Biocontamination Control for Pharmaceuticals and Healthcare, 2019. [Electronic resource]. Access mode: https:// www.sciencedirect.com/topics/medicine-and-dentistry/environmental-monitoring (circulation date 12.12.2019).
  4. Sandle T. Microbiology laboratory techniques. Pharmaceutical Microbiology, 2016. [Electronic resource]. Access mode: https:// www.sciencedirect.com/topics/medicine-and-dentistry/environmental-monitoring (circulation date 12/12/2019).
  5. Pravila GMP – elektronnaja sistema obuchenija. [Elektronnyj resurs]. Rezhim dostupa: https://e-learning.favea.org/instructions/presentation (data obraschenija 12.12.2019). [Rules of GMP – electronic learning system. [Electronic resource]: Access mode: https://e-learning.favea.org/instructions/presentation (circulation date 12.12.2019). (in Russian)].
  6. European Pharmacopoeia Online.European Directorate for the Quality of Medicines, 2017. [Electronic resource]. Access mode: https://online.edqm.eu/ (circulation date 12/12/2019).
  7. Salaman-Byron A.L. Limitations of microbiological environmental monitoring methods in cleanrooms. Research & Development, 2018. [Electronic resource]. Access mode: https:// www.americanpharmaceuticalreview.com/Featured-Articles/349192-Limitations-of-Microbial-Environmental-Monitoring-Methods-in-Cleanrooms/ ( circulation date 12/12/2019).
  8. Sandle T. Viable Environmental Monitoring Methods. Biocontamination Control for Pharmaceuticals and Healthcare, 2019. [Electronic resource]. Access mode: https:// www.sciencedirect.com/topics/medicine-and-dentistry/environmental-monitoring/ (circulation date 12/12/2019).
  9. United States Pharmacopoeia. Vol 40 Microbiological characterization, identification and typing of strains. Rockville, Maryland, USA. 2015.
  10. Riley B. Rapid Microbiology Methods in the Pharmaceutical Industry. American pharmaceutical review, 2006 [Electronic resource] Access mode: https://www.americanpharmaceuticalreview.com/Featured-Articles/113094-Rapid-Microbiology-Methods-in-the-Pharmaceutical-Industry/( circulation date 12/12/2019).
  11. Gunar O.V., Sahno N.G. Kolichestvennoe opredelenie mikroorganizmov-kontaminantov lekarstvennyh sredstv s ispol'zovaniem sistemy «Milliflex® quantum». Farmatsija. 2019; 68 (3): 5–11. [Gunar O.V., Sakhno N.G. Quantitative detection of microbial contaminants of drugs, by using the «Milliflex® quantum system». Farmatsiya. 2019; 68 (3): 5–11 (in Russian)].
  12. Dalmaso G., Denoya C. Qualification of environmental monitoring program.Technical marking, 2015. [Electronic resource]. Access mode: https:// www.americanpharmaceuticalreview.com/Featured-Articles/349192-Limitations-of-Microbial-Environmental-Monitoring-Methods-in-Cleanrooms/ (circulation date 12/12/2019).